Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation

American Journal of Cardiology

Volumn 107, Issue 2, 2011, Pages 186-194

  Rossini, Roberta ^a   Capodanno, Davide ^b   Lettieri, Corrado ^c   Musumeci, Giuseppe ^a   Nijaradze, Tamar ^a   Romano, Michele ^c   Lortkipanidze, Nikoloz ^a   Cicorella, Nicola ^c   Biondi Zoccai, Giuseppe ^d   Sirbu, Vasile ^a   Izzo, Antonio ^c   Guagliumi, Giulio ^a   Valsecchi, Orazio ^a   Gavazzi, Antonello ^a   Angiolillo, Dominick J ^b  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c CARLO POMA HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; PROTON PUMP INHIBITOR; RAPAMYCIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ELUTING STENT; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART INJURY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; STENT THROMBOSIS; STROKE;

ADMINISTRATION, ORAL; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 78650917078     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.08.067     Document Type: Article

References (33)

1. P.W. Serruys, M. Degertekin, K. Tanabe, A. Abizaid, J.E. Sousa, A. Colombo, G. Guagliumi, W. Wijns, W.K. Lindeboom, J. Ligthart, P.J. de Feyter, M.C. Morice RAVEL Study Group Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions) trial Circulation 106 2002 798 803
2. A. Colombo, J. Drzewiecki, A. Banning, E. Grube, K. Hauptmann, S. Silber, D. Dudek, S. Fort, F. Schiele, K. Zmudka, G. Guagliumi, M.E. Russell TAXUS II Study Group Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
3. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein, J.L. Jaeger, R.E. Kuntz SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
4. G.W. Stone, S.G. Ellis, C.D. O'Shaughnessy, S.L. Martin, L. Satler, T. McGarry, M.A. Turco, D.J. Kereiakes, L. Kelley, J.J. Popma, M.E. Russell Taxus V ISR Investigators Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 2006 1253 1263
5. M.N. Babapulle, and M.J. Eisenberg Coated stents for the prevention of restenosis part II Circulation 106 2002 2859 2866
6. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
7. A.V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M.C. John, H.K. Gold, and R. Virmani Pathological correlates of late DES thrombosis Circulation 115 2007 2435 2441
8. R. Virmani, G. Guagliumi, A. Farb, G. Musumeci, N. Grieco, T. Motta, L. Mihalcsik, M. Tespili, O. Valsecchi, and F.D. Kolodgie Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
9. E. Stabile, E. Cheneau, T. Kinnaird, W.O. Suddath, N.J. Weissman, R. Torguson, K.M. Kent, A.D. Pichard, L.F. Satler, and R. Waksman Late thrombosis in cypher stents after the discontinuation of antiplatelet therapy Cardiovasc Radiat Med 5 2004 173 176 (Pubitemid 44556561)
10. A.T. Ong, E.P. McFadden, E. Regar, P.P. de Jaegere, R.T. van Domburg, and P.W. Serruys Late angiographic stent thrombosis (LAST) events with drug-eluting stents J Am Coll Cardiol 45 2005 2088 2092
11. E.P. McFadden, E. Stabile, E. Regar, E. Cheneau, A.T. Ong, T. Kinnaird, W.O. Suddath, N.J. Weissman, R. Torguson, K.M. Kent, A.D. Pichard, L.F. Satler, R. Waksman, and P.W. Serruys Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521 (Pubitemid 39410418)
12. F. Airoldi, A. Colombo, N. Morici, A. Latib, J. Cosgrave, L. Buellesfeld, E. Bonizzoni, M. Carlino, U. Gerckens, C. Godino, G. Melzi, I. Michev, M. Montorfano, G.M. Sangiorgi, A. Qasim, A. Chieffo, C. Briguori, and E. Grube Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment Circulation 116 2007 745 754
13. S. Schulz, T. Schuster, J. Mehilli, R.A. Byrne, J. Ellert, S. Massberg, J. Goedel, O. Bruskina, K. Ulm, A. Schmig, and A. Kastrati Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period Eur Heart J 30 2009 2714 2721
14. I. Iakovou, T. Schmidt, E. Bonizzoni, I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, and A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
15. C.L. Grines, R.O. Bonow, D.E. Casey Jr., T.J. Gardner, P.B. Lockhart, D.J. Moliterno, P. O'Gara, and P. Whitlow A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, American Dental Association, American College of Physicians Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians Circulation 115 2007 813 818
16. F.G. Kushner, M. Hand, S.C. Smith Jr, S.B. King III, J.L. Anderson, E.M. Antman, S.R. Bailey, E.R. Bates, J.C. Blankenship, D.E. Casey Jr, L.A. Green, J.S. Hochman, A.K. Jacobs, H.M. Krumholz, D.A. Morrison, J.P. Ornato, D.L. Pearle, E.D. Peterson, M.A. Sloan, P.L. Whitlow, and D.O. Williams 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
17. J.A. Spertus, R. Kettelkamp, C. Vance, C. Decker, P.G. Jones, J.S. Rumsfeld, J.C. Messenger, S. Khanal, E.D. Peterson, R.G. Bach, H.M. Krumholz, and D.J. Cohen Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
18. T. Cuisset, C. Frere, J. Quilici, B. Gaborit, L. Bali, R. Poyet, D. Faille, P.E. Morange, M.C. Alessi, and J.L. Bonnet Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting Am Heart J 157 2009 889 893
19. T. Kimura, T. Morimoto, Y. Nakagawa, T. Tamura, K. Kadota, H. Yasumoto, H. Nishikawa, Y. Hiasa, T. Muramatsu, T. Meguro, N. Inoue, H. Honda, Y. Hayashi, S. Miyazaki, S. Oshima, T. Honda, N. Shiode, M. Namura, T. Sone, M. Nobuyoshi, T. Kita, K. Mitsudo j-Cypher Registry Investigators Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation Circulation 119 2009 987 995
20. M.J. Eisenberg, P.R. Richard, D. Libersan, and K.B. Filion Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents Circulation 119 2009 1634 1642
21. P. Eriksson Long-term clopidogrel therapy after percutaneous coronary intervention in PCI-CURE and CREDO: the "Emperor's New Clothes" revisited Eur Heart J 25 2004 720 722
22. E.L. Eisenstein, K.J. Anstrom, D.F. Kong, L.K. Shaw, R.H. Tuttle, D.B. Mark, J.M. Kramer, R.A. Harrington, D.B. Matchar, D.E. Kandzari, E.D. Peterson, K.A. Schulman, and R.M. Califf Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation JAMA 297 2007 159 168
23. J.W. van Werkum, A.A. Heestermans, A.C. Zomer, J.C. Kelder, M.J. Suttorp, B.J. Rensing, J.J. Koolen, B.R. Brueren, J.H. Dambrink, R.W. Hautvast, F.W. Verheugt, and B.J.M. Ten Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 2009 1399 1409
24. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
25. A.K. Rao, C. Pratt, A. Berke, A. Jaffe, I. Ockene, T.L. Schreiber, W.R. Bell, G. Knatterud, T.L. Robertson, and M.L. Terrin Thrombolysis In Myocardial Infarction (TIMI) Trialphase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
26. J.W. Riddell, L. Chiche, B. Plaud, and M. Hamon Coronary stents and noncardiac surgery Circulation 116 2007 e378 e382
27. E. Cheneau, L. Leborgne, G.S. Mintz, J. Kotani, A.D. Pichard, L.F. Satler, D. Canos, M. Castagna, N.J. Weissman, and R. Waksman Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study Circulation 108 2003 43 47
28. D.E. Cutlip, D.S. Baim, K.K. Ho, J.J. Popma, A.J. Lansky, D.J. Cohen, J.P. Carrozza Jr., M.S. Chauhan, O. Rodriguez, and R.E. Kuntz Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
29. A. Jeremias, B. Sylvia, J. Bridges, A.J. Kirtane, B. Bigelow, D.S. Pinto, K.K. Ho, D.J. Cohen, L.A. Garcia, D.E. Cutlip, and J.P. Carrozza Jr Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 2004 1930 1932
30. P.M. Ho, E.D. Peterson, L. Wang, D.J. Magid, S.D. Fihn, G.C. Larsen, R.A. Jesse, and J.S. Rumsfeld Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome JAMA 299 2008 532 539
31. J. Saw, E.H. Madsen, S. Chan, and E. Maurer-Spurej The ELAPSE (Evaluation of Long-Term Clopidogrel Antiplatelet and Systemic Anti-Inflammatory Effects) study J Am Coll Cardiol 52 2008 1826 1833
32. S.-J. Park, D.-W. Park, Y.-H. Kim, S.J. Kang, S.W. Lee, C.W. Lee, K.H. Han, S.W. Park, S.C. Yun, S.G. Lee, S.W. Rha, I.W. Seong, M.H. Jeong, S.H. Hur, N.H. Lee, J. Yoon, J.Y. Yang, B.K. Lee, Y.J. Choi, W.S. Chung, D.S. Lim, S.S. Cheong, K.S. Kim, J.K. Chae, D.Y. Nah, D.S. Jeon, K.B. Seung, J.S. Jang, H.S. Park, and K. Lee Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
33. D.E. Kandzari, D.J. Angiolillo, M.J. Price, and P.S. Teirstein Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization J Am Coll Cardiol Cardiovasc Interv 2 2009 1279 1285